Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Newly appointed CEO Brian Hullinger receives inducement grant option to purchase up to 300,000 shares of common stock
- Options awarded in three tranches with vesting periods
- Psychemedics Corporation is the world's largest provider of hair testing for drugs of abuse
- None.
ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its newly appointed President and Chief Executive Officer, Brian Hullinger, upon his entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Mr. Hullinger received an inducement grant option to purchase up to 300,000 shares of common stock. The inducement awards were granted on August 17, 2023, Mr. Hullinger’s hire date as the Chief Executive Officer, and also the date on which he was elected to the Psychemedics Corporation Board of Directors. The options have a ten-year term and an exercise price of
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over
The Psychemedics Corporation web site is www.psychemedics.com
Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@Psychemedics.com